Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy

Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy

BackgroundThe purpose of this study was set to investigate the prognostic role of plasmatic levels of heat shock protein 90 alpha (HSP90α) at diagnosis in advanced lung cancer patients treated with Programmed cell death protein 1 (PD-1)/Programmed cell death-Ligand protein 1 (PD-L1) inhibitors plus...

Full description

Bibliographic Details
Main Authors: Shubin Chen, Qitao Yu, Shaozhang Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Oncology
Subjects:
advanced lung cancer
HSP90α
PD-1/PD-L1 inhibitors
chemotherapy
prognostic marker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.765115/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.765115/full

Similar Items